FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2176245890> ?p ?o ?g. }

• W2176245890 endingPage "7366" @default.
• W2176245890 startingPage "7362" @default.
• W2176245890 abstract "Vancomycin-resistant urinary tract infections are often challenging to treat. This retrospective cohort study compared outcomes between patients treated for vancomycin-resistant enterococcal urinary tract infection with an aminopenicillin and those treated with a non-β-lactam antibiotic. Inpatients treated with an enterococcus-active agent for their first symptomatic vancomycin-resistant enterococcal urinary tract infection between 1 January 2012 and 31 December 2013 were considered for inclusion. Patients with colonization, on hospice, or receiving comfort care only were excluded. The primary endpoint of clinical cure was defined as resolution of clinical symptoms, or symptom improvement to the extent that no additional antibacterial drug therapy was necessary, and lack of microbiologic persistence. Secondary endpoints of 30-day readmission or retreatment and 30-day all-cause mortality were also compared. A total of 316 urinary isolates were screened, and 61 patients with symptomatic urinary tract infection were included. Twenty (35%) of the 57 isolates tested were ampicillin susceptible. Thirty-one patients received an aminopenicillin, and 30 received a non-β-lactam. Rates of clinical cure for aminopenicillin versus non-β-lactam treatment were 26/31 (83.9%) and 22/30 (73.3%) (P = 0.315), respectively. Rates of 30-day readmission (6/31, or 19.4%, versus 9/30, or 30%, respectively; P = 0.334), 30-day retreatment (4/31, or 12.9%, versus 4/30, 13.3%, respectively; P = 0.960), and 30-day all-cause mortality (2/31, or 6.5%, versus 1/30, or 3.3%, respectively; P = 0.573) were also not significantly different between groups. Aminopenicillins may be a viable option for treating vancomycin-resistant urinary tract infection regardless of the organism's ampicillin susceptibility. Prospective validation with larger cohorts of patients should be considered." @default.
• W2176245890 created "2016-06-24" @default.
• W2176245890 creator A5007517600 @default.
• W2176245890 creator A5009039786 @default.
• W2176245890 creator A5019297175 @default.
• W2176245890 creator A5030511279 @default.
• W2176245890 creator A5034161489 @default.
• W2176245890 creator A5045626390 @default.
• W2176245890 creator A5056522170 @default.
• W2176245890 date "2015-12-01" @default.
• W2176245890 modified "2023-10-17" @default.
• W2176245890 title "Outcomes of Aminopenicillin Therapy for Vancomycin-Resistant Enterococcal Urinary Tract Infections" @default.
• W2176245890 cites W1965094779 @default.
• W2176245890 cites W1968983558 @default.
• W2176245890 cites W2025744614 @default.
• W2176245890 cites W2053899751 @default.
• W2176245890 cites W2072607258 @default.
• W2176245890 cites W2087865186 @default.
• W2176245890 cites W2092981599 @default.
• W2176245890 cites W2110242414 @default.
• W2176245890 cites W2110515634 @default.
• W2176245890 cites W2128442462 @default.
• W2176245890 cites W2166764122 @default.
• W2176245890 cites W2167004380 @default.
• W2176245890 cites W2338858887 @default.
• W2176245890 doi "https://doi.org/10.1128/aac.01817-15" @default.
• W2176245890 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4649236" @default.
• W2176245890 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26369973" @default.
• W2176245890 hasPublicationYear "2015" @default.
• W2176245890 type Work @default.
• W2176245890 sameAs 2176245890 @default.
• W2176245890 citedByCount "17" @default.
• W2176245890 countsByYear W21762458902016 @default.
• W2176245890 countsByYear W21762458902017 @default.
• W2176245890 countsByYear W21762458902018 @default.
• W2176245890 countsByYear W21762458902019 @default.
• W2176245890 countsByYear W21762458902020 @default.
• W2176245890 countsByYear W21762458902021 @default.
• W2176245890 countsByYear W21762458902022 @default.
• W2176245890 countsByYear W21762458902023 @default.
• W2176245890 crossrefType "journal-article" @default.
• W2176245890 hasAuthorship W2176245890A5007517600 @default.
• W2176245890 hasAuthorship W2176245890A5009039786 @default.
• W2176245890 hasAuthorship W2176245890A5019297175 @default.
• W2176245890 hasAuthorship W2176245890A5030511279 @default.
• W2176245890 hasAuthorship W2176245890A5034161489 @default.
• W2176245890 hasAuthorship W2176245890A5045626390 @default.
• W2176245890 hasAuthorship W2176245890A5056522170 @default.
• W2176245890 hasBestOaLocation W21762458901 @default.
• W2176245890 hasConcept C126322002 @default.
• W2176245890 hasConcept C141071460 @default.
• W2176245890 hasConcept C203092338 @default.
• W2176245890 hasConcept C2776021129 @default.
• W2176245890 hasConcept C2778980435 @default.
• W2176245890 hasConcept C2779489039 @default.
• W2176245890 hasConcept C2780585763 @default.
• W2176245890 hasConcept C501593827 @default.
• W2176245890 hasConcept C523546767 @default.
• W2176245890 hasConcept C535046627 @default.
• W2176245890 hasConcept C54355233 @default.
• W2176245890 hasConcept C71924100 @default.
• W2176245890 hasConcept C77411442 @default.
• W2176245890 hasConcept C86803240 @default.
• W2176245890 hasConcept C89423630 @default.
• W2176245890 hasConcept C90924648 @default.
• W2176245890 hasConceptScore W2176245890C126322002 @default.
• W2176245890 hasConceptScore W2176245890C141071460 @default.
• W2176245890 hasConceptScore W2176245890C203092338 @default.
• W2176245890 hasConceptScore W2176245890C2776021129 @default.
• W2176245890 hasConceptScore W2176245890C2778980435 @default.
• W2176245890 hasConceptScore W2176245890C2779489039 @default.
• W2176245890 hasConceptScore W2176245890C2780585763 @default.
• W2176245890 hasConceptScore W2176245890C501593827 @default.
• W2176245890 hasConceptScore W2176245890C523546767 @default.
• W2176245890 hasConceptScore W2176245890C535046627 @default.
• W2176245890 hasConceptScore W2176245890C54355233 @default.
• W2176245890 hasConceptScore W2176245890C71924100 @default.
• W2176245890 hasConceptScore W2176245890C77411442 @default.
• W2176245890 hasConceptScore W2176245890C86803240 @default.
• W2176245890 hasConceptScore W2176245890C89423630 @default.
• W2176245890 hasConceptScore W2176245890C90924648 @default.
• W2176245890 hasIssue "12" @default.
• W2176245890 hasLocation W21762458901 @default.
• W2176245890 hasLocation W21762458902 @default.
• W2176245890 hasLocation W21762458903 @default.
• W2176245890 hasLocation W21762458904 @default.
• W2176245890 hasOpenAccess W2176245890 @default.
• W2176245890 hasPrimaryLocation W21762458901 @default.
• W2176245890 hasRelatedWork W179362946 @default.
• W2176245890 hasRelatedWork W2013660900 @default.
• W2176245890 hasRelatedWork W2014335702 @default.
• W2176245890 hasRelatedWork W2019653013 @default.
• W2176245890 hasRelatedWork W2023642997 @default.
• W2176245890 hasRelatedWork W2116268626 @default.
• W2176245890 hasRelatedWork W2158746256 @default.
• W2176245890 hasRelatedWork W2337784801 @default.
• W2176245890 hasRelatedWork W2403318254 @default.
• W2176245890 hasRelatedWork W4310623540 @default.

• next